276
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

A Case of Idiopathic Retinitis Vasculitis Aneurysms and Neuroretinitis (IRVAN) Treated with Adalimumab

, MS, , MD, , DNB, , MD & , DNB
Pages 627-630 | Received 20 Sep 2021, Accepted 23 Nov 2021, Published online: 22 Mar 2022

References

  • Chang TS, Aylward GW, Davis JL, et al. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis: retinal vasculitis study. Ophthalmology. 1995;102:1089–1097. doi:10.1016/S0161-6420(95)30907-4.
  • Samuel MA, Equi RA, Chang TS, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology. 2007;114:1526–1529. doi:10.1016/j.ophtha.2006.11.014.
  • Kumawat D, Kumar V. Resolution of arterial aneurysms in idiopathic retinal vasculitis, aneurysms and neuroretinitis: a case report and review of literature. Int Ophthalmol. 2019;39:1155–1161. doi:10.1007/s10792-018-0913-3.
  • Balaratnasingam C, Yannuzzi LA, Franchina M, Freund KB. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) in a patient without IRVAN history. JAMA Ophthalmol. 2019;137(2):230–232. doi:10.1001/jamaophthalmol.2018.5247.
  • Cheema RA, Al-Askar E, Cheema HR. Infliximab therapy for idiopathic retinal vasculitis, aneurysm, and neuroretinitis syndrome. J Ocul Pharmacol Ther. Aug, 2011;27(4):407–410. doi:10.1089/jop.2010.0189. Epub 2011 May 12.
  • Karasu B, Özkan D, Erdoğan G, Ö A. The fluorescein angiographic photodiagnosis of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: outcome of combined therapy. Photodiagnosis Photodyn Ther. Sep, 2019;27:336–339. doi:10.1016/j.pdpdt.2019.06.013.
  • Saatci A,O, Ayhan Z, Takeş Ö, et al. Single bilateral dexamethasone implant in addition to panretinal photocoagulation and oral azathioprine treatment in IRVAN syndrome. Case Rep Ophthalmol. 2015;6:56–62. doi:10.1159/000375481.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.